Antitumour effect of a mixture of n-propyl polysulfides in vitro

Open access


Copper serves as a limiting factor for multiple steps of tumour progression, including angiogenesis, growth and metastasis. High levels of copper have been found in a wide spectrum of human cancers. Antitumour activities of copper-chelating drugs have been reported in animal models. Organosulfur compounds (diallyl sulfi de, DAS; diallyl disulfi de, DADS; S-ethylcysteine, SEC; N-acetylcysteine, NAC) derived from garlic exhibit marked copper- chelating activity. We analysed a mixture of fi fteen n-propyl polysulfi des (DPPS) for potential antitumour activity against several murine tumour cell lines, including colon carcinoma (CT26), mammary carcinoma (4T1) and melanoma cell lines (B16F10), and compared the eff ects with the antiproliferative eff ect in highly proliferative murine mesenchymal stem cells (mMSCs). Th e eff ects of the mixture of n-propyl polysulfi des (100%) on cell viability were determined using MTT assays. Cell apoptosis was analysed using Annexin V-FITC/PI assays. Th e results of the MTT assays indicate that this standardized mixture of n-propyl polysulfi des has a strong, dose-dependent cytotoxic eff ect against all three of the tested tumour cell lines (CT26, 4T1, B16F10). Th e cytotoxic eff ect of the n-propyl polysulfi de mixture against the CT26 and B16F10 cell lines was much stronger than that of cisplatin and was signifi cantly weaker in mMSCs, which are non-cancerous and highly proliferative cells, than in cancer cells. Flow cytometric analysis of CT26 and 4T1 cells revealed that apoptosis was not the dominant mechanism of cell death induced by the n-propyl polysulfi de mixture. Th e n-propyl polysulfi de mixture exerted highly cytotoxic activity against murine colon carcinoma and melanoma cell lines, but its antiproliferative activity against mMSCs was signifi cantly lower than that of cisplatin.

1. Grubman A, & White AR. (2014). Copper as a key regulator of cell signalling pathways. Expert Rev Mol Med. 16:e11. doi:

2. Turski ML, & Thiele DJ. (2009). New roles for copper metabolism in cell proliferation, signaling, and disease. J. Biol. Chem. 284:717-721.

3. Denoyer D, Masaldan S, La Fontaine S, & Cater MA. (2015). Targeting copper in cancer therapy: ‘Copper That Cancer’. Metallomics.7(11):1459-76.

4. Hanahan D, & Weinberg RA. (2011). Hallmarks of cancer: The next generation. Cell. 144:646-674.

5. Gupte A, & Mumper RJ. (2009). Elevated copper and oxidative stress in cancer cells as a target for cancer treatment. Cancer Treat Rev. 35(1):32-46.

6. Kuo HW, Chen SF, Wu CC, Chen DR, & Lee JH. (2002). Serum and tissue trace elements in patients with breast cancer in Taiwan. Biol Trace Elem Res. 89(1):1-11.

7. Zuo XL, Chen JM, Zhou X, Li XZ, & Mei GY. (2006). Levels of selenium, zinc, copper, and antioxidant enzyme activity in patients with leukemia. Biol Trace Elem Res. 114(1-3):41-53.

8. Nayak SB, Bhat VR, Upadhyay D, & Udupa SL. (2003). Copper and ceruloplasmin status in serum of prostate and colon cancer patients. Indian J Physiol Pharmacol. 47(1):108-10.

9. Habib FK, Dembinski TC, & Stitch SR. (1980). The zinc and copper content of blood leucocytes and plasma from patients with benign and malignant prostates. Clin Chim Acta. 104(3):329-35.

10. J.L., Diez M. Arroyo M. Cerdan F.J. Munoz M. Martin M.A. & Balibrea J.L. (1989). Serum and Tissue Trace Metal Levels in Lung Cancer. Oncology; 46:230-234 .

11. Brem S, Grossman SA, Carson KA, New P, Phuphanich S, Alavi JB, Mikkelsen T, & Fisher JD. (2005). Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma. Neuro Oncol. 7(3):246-53.

12. Yoshii J, Yoshiji H, Kuriyama S, Ikenaka Y, Noguchi R, Okuda H, Tsujinoue H, Nakatani T, Kishida H, Nakae D, Gomez DE, De Lorenzo MS, Tejera AM, & Fukui H. (2001). The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells. Int J Cancer. 94(6):768-773.

13. Ishida S, Andreux P, Poitry-Yamate C, Auwerx J, & Hanahan D. (2013). Bioavailable copper modulates oxidative phosphorylation and growth of tumors. Proc Natl Acad Sci U S A.110(48):19507-12.

14. Shun Li, Jing Zhang, Hong Yang, Chunhui Wu, Xitong Dang, & Yiyao Liua. (2015). Copper depletion inhibits CoCl2-induced aggressive phenotype of MCF-7 cells via downregulation of HIF-1 and inhibition of Snail/ Twist-mediated epithelial-mesenchymal transition. Sci Rep. 5: 12410.

15. Ou CC, Tsao SM, Lin MC, & Yin MC. (2003). Protective action on human LDL against oxidation and glycation by four organosulfur compounds derived from garlic. Lipids. 38(3):219-24.

16. Campos JF, de Castro DT, Damiao MJ, Vieira Torquato HF, Paredes-Gamero EJ, Carollo CA, Estevinho LM, de Picoli Souza K, & Dos Santos EL. (2016). The Chemical Profile of Senna velutina Leaves and Their Antioxidant and Cytotoxic Effects. Oxid Med Cell Longev. 2016:8405957.

17. Flora SJ, & Pachauri V. (2010). Chelation in metal intoxication. Int J Environ Res Public Health. 7(7):2745-88.

18. Yoshii J, Yoshiji H, Kuriyama S, Ikenaka Y, Noguchi R, Okuda H, Tsujinoue H, Nakatani T, Kishida H, Nakae D, Gomez DE, De Lorenzo MS, Tejera AM, & Fukui H. (2001). The copper-chelating agent, trientine, sup presses tumor development and angiogenesis in the murine hepatocellular carcinoma cells. Int J Cancer. 15;94(6):768-73.

19. Yoshiji H1, Yoshii J, Kuriyama S, Ikenaka Y, Noguchi R, Yanase K, Namisaki T, Kitade M, Yamazaki M, & Fukui H. (2005). Combination of copper-chelating agent, trientine, and methotrexate attenuates colorectal carcinoma development and angiogenesis in mice. Oncol Rep. 14(1):213-8.

20. Zhang W, Chen C, Shi H, Yang M, Liu Y, Ji P, Chen H, Tan RX, & Li E. (2016). Curcumin is a biologically active copper chelator with antitumor activity. Phytomedicine. 15;23(1):1-8.

21. Kenyon G Daniel, Di Chen, Shirley Orlu, Qiuzhi Cindy Cui, Fred R Miller, & Q Ping Dou. (2005).Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells. Breast Cancer Res. 7(6): R897-R908.

22. Hellman NE, & Gitlin JD. (2002). Ceruloplasmin metabolism and function. Annu Rev Nutr. 22:439-58.

23. Ohrvik H, & Thiele DJ. (2014).How copper traverses cellular membranes through the mammalian copper transporter 1, Ctr1. Ann N Y Acad Sci. 1314:32-41.

24. AC. Rosenzweig. (2001). Copper delivery by metallochaperone proteins. Acc Chem Res.34(2):119-28.

25. Wang J, Luo C, Shan C, You Q, Lu J, Elf S, Zhou Y, Wen Y, Vinkenborg JL, Fan J, Kang H, Lin R, Han D, Xie Y, Karpus J, Chen S, Ouyang S, Luan C, Zhang N, Ding H, Merkx M, Liu H, Chen J, Jiang H, & He C. (2015). Inhibition of human copper trafficking by a small molecule significantly attenuates cancer cell proliferation. Nat Chem. 7(12):968-79.

26. Fatfat M, Merhi RA, Rahal O, Stoyanovsky DA, Zaki A, Haidar H, Kagan VE, Gali-Muhtasib H1, & Machaca K. (2014). Copper chelation selectively kills colon cancer cells through redox cycling and generation of reactive oxygen species. BMC Cancer. 21;14:527.

27. Lemar KM, Aon MA, Cortassa S, O’Rourke B, Muller CT, Lloyd D. (2007). Diallyl disulphide depletes glutathione in Candida albicans. Yeast. 24(8):695-706.

Serbian Journal of Experimental and Clinical Research

The Journal of Faculty of Medical Sciences, University of Kragujevac

Journal Information

CiteScore 2018: 0.13

SCImago Journal Rank (SJR) 2018: 0.118
Source Normalized Impact per Paper (SNIP) 2018: 0.079


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 122 122 30
PDF Downloads 117 117 17